Effect of exenatide on gastric emptying and graft survival in islet allograft recipients

Transplantation Proceedings

Volumn 43, Issue 9, 2011, Pages 3231-3234

  Peixoto, E M L ^a   Froud, T ^a   Gomes, L S ^a   Zavala, L Mireles ^a   Corrales, A ^a   Herrada, E ^a   Ricordi, C ^a   Alejandro, R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; EXENDIN 4; GLUCAGON; GLUCOSE; PARACETAMOL; SITAGLIPTIN;

BLOOD GLUCOSE MONITORING; CLINICAL EVALUATION; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG ABSORPTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GRAFT DYSFUNCTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HEARTBURN; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LONG TERM CARE; MAJOR CLINICAL STUDY; NAUSEA; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; STOMACH EMPTYING; STOMACH PARESIS; TREATMENT DURATION;

ACETAMINOPHEN; C-PEPTIDE; CELL TRANSPLANTATION; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTRIC EMPTYING; GLUCOSE; GRAFT SURVIVAL; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; PEPTIDES; VENOMS;

EID: 81455143467     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.10.022     Document Type: Conference Paper

References (11)

1. D. Mineo, A. Pileggi, and R. Alejandro Point: Stead progress and current challenges in clinical islet transplantation Diabetes Care 32 2009 1563
2. A.M. Shapiro, C. Ricordi, and B.I. Hering International trial of the Edmonto protocol for islet transplantation N Engl J Med 355 2006 1318
3. R.N. Faradji, T. Froud, and A. Pileggi Islet alone and islet after kidney transplantation at the University of Miami: an update Transplantation 82 2006 340
4. R.N. Faradji, K.P. Monroy, and S. Messinger Simple measures to monitor β-cell mass and assess islet graft dysfunction Am J Transplant 7 2007 303
5. T. Froud, R.N. Faradji, and A. Pileggi The use of exenatide in islet transplant recipients with chronic allograft dysfunction: safety, efficacy, and metabolic effects Transplantation 86 2008 36
6. R.J. Brown, N. Sinaii, and K.I. Rother Too much glucagon, too little insulin: time course of pancreatic islet dysfunction in new-onset type 1 diabetes Diabetes Care 31 2008 1403
7. V. Lagari-Libhaber, S. Messinger-Cayetano, and D. Baidal Glucagon response to hyperglycemia following islet cell transplantation in type 1 diabetes mellitus Poster presentation at Endocrine Society Scientific Meeting June 1013 2009 Washington DC
8. R.N. Faradji, T. Froud, and S. Messinger Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction Cell Transplant 18 2009 1247
9. S.R. Cechin, I. Perez-Alvarez, and M.S. Ochoa Exenatide (Byetta) activates anti-inflammatory and anti-apoptotic pathways in human pancreatic islets Diabetes 57 S1 2008 A466 abstract number 1678-P
10. T. Froud, C. Ricordi, and D.A. Baidal Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience Am J Transplant 5 2005 2037
11. C.B. Leito, T. Tharavanij, and P. Cure Restoration of hypoglycemia awareness after islet transplantation Diabetes Care 31 2008 2113